in a randomized , double-blind , three-way cross-over study in 11 female volunteers is-5-mn 30 mg proved to be more potent with respect to pharmacological activity than sustained released isdn 20 mg ( isosorbide dinitrate ) , whereas there was no difference in side-effects .
C0064079
is-5-mn
C0022252
isosorbide